A systematic review of antimicrobial therapy in children with tracheostomies
Pediatric Pulmonology · 2024
DOI: 10.1002/ppul.26766 ↗At a glance
Systematische Übersicht in Pediatric Pulmonology, 2024. Written by Helen Pearce and 4 co-authors. Institution: Biosciences Institute, William Leech Building, Newcastle University, Newcastle Upon Tyne, UK. Major MEDLINE topics: Tracheostomy, Respiratory Tract Infections. Cited 3 times so far (Crossref); 50 references. The full text is freely available (open access, CC BY-NC 4.0). Funded by: Medical Research Council.
Topics: Kinderkrankenpflege
Abstract (original language)
Tracheostomies are indicated in children to facilitate long‐term ventilatory support, aid in the management of secretions, or manage upper airway obstruction. Children with tracheostomies often experience ongoing airway complications, of which respiratory tract infections are common. They subsequently receive frequent courses of broad‐spectrum antimicrobials for the prevention or treatment of respiratory tract infections. However, there is little consensus in practice with regard to the indication for treatment/prophylactic antimicrobial use, choice of antimicrobial, route of administration, or duration of treatment between different centers. Routine antibiotic use is associated with adverse effects and an increased risk of antimicrobial resistance. Tracheal cultures are commonly obtained from pediatric tracheostomy patients, with the aim of helping guide antimicrobial therapy choice. However, a positive culture alone is not diagnostic of infection and the role of routine surveillance cultures remains contentious. Inhaled antimicrobial use is also widespread in the management of tracheostomy‐associated infections; this is largely based on the theoretical benefits of higher airway antibiotic concentrations. The role of prophylactic inhaled antimicrobial use for tracheostomy‐associated infections remains largely unproven. This systematic review summarizes the current evidence base for antimicrobial selection, duration, and administration route in pediatric tracheostomy‐associated infections. It also highlights significant variation in practice between centers and the urgent need for further prospective evidence to guide the management of these vulnerable patients.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Biosciences Institute, William Leech Building, Newcastle University, Newcastle Upon Tyne, UK.
- Department of Paediatric Otolaryngology, Great North Children's Hospital, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle Upon Tyne, UK.
- Department of Paediatric Respiratory Medicine, Great North Children's Hospital, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle Upon Tyne, NE1 4LP.
- Translational and Clinical Research Institute, William Leech Building, Newcastle University, Newcastle Upon Tyne, UK.
ORCID profiles: Helen Pearce, Benjamin James Talks, Steven Powell, Malcolm Brodlie, Jason Powell
Funding
- Medical Research Council
Cite
APA
Pearce, H., Talks, B. J., Powell, S., Brodlie, M., & Powell, J. (2024). A systematic review of antimicrobial therapy in children with tracheostomies. Pediatric Pulmonology. https://doi.org/10.1002/ppul.26766
Vancouver
Pearce H, Talks BJ, Powell S, Brodlie M, Powell J. A systematic review of antimicrobial therapy in children with tracheostomies. Pediatric Pulmonology. 2024. doi:10.1002/ppul.26766
BibTeX
@article{Pearce2024,
author = {Pearce, Helen and Talks, Benjamin James and Powell, Steven and Brodlie, Malcolm and Powell, Jason},
title = {A systematic review of antimicrobial therapy in children with tracheostomies},
journal = {Pediatric Pulmonology},
year = {2024},
doi = {10.1002/ppul.26766}
}
EUVIMED